Burning Rock Biotech Limited
BNR
|
$0.866
0.7%
20K
|
Health Services
(0.0% 1d) (20.9% 1m) (-69.1% 1y) (0.0% 2d) (0.0% 3d) (19.4% 7d) (162.88% volume)
Earnings Calendar:
Market Cap: $ 91,311,923
http://www.brbiotech.com
Sec Filling | Patents | 705 employees
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The company operates through following segment: central laboratory business, in-hospital business and pharma research and development services. Its products and clinical applications including companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. Burning Rock Biotech was founded by Yu Sheng Han in 2014 and is headquartered in Guangzhou, China.
china immunotherapy diagnostics
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 88% | 12% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.14 39.56% 7.6M
|
Finance
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
CMAX | $4.12 28.35% 65K
|
Manufacturing
Last 48 Hours Insiders Buying
TPL P 3 | $585.25 -0.1% 4.7K
|
Miscellaneous
|
15:00
ETST P 79000 | $0.065 110K
|
Manufacturing
|
11:30
MCFT P 26039 | $21.57 0.33% 46K
|
Consumer Durables
|
00:00
YORW P 29 | $35.6 0.51% 11K
|
Utilities
|
19:01
VUZI P 14500 | $1.34 -0.74% 84K
|
Electronic Technology
|
17:00
BANF P 256 | $92.43 1.26% 5.7K
|
Finance
|
15:30
RMCF | $3.57 170
|
Consumer Non-Durables
|
20:10